Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K.C. Lam
P1.01-98 a Phase IIIb Trial of Afatinib in EGFRm+ NSCLC: Analyses of Outcomes in Patients With Brain Metastases or Dose Reductions
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
OA07.02 ATOM: A Phase II Study to Assess Efficacy of Preemptive Local Ablative Therapy to Residual Oligometastases After EGFR TKI
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Related publications
P1.01-92 a Phase II Study of Afatinib Treatment for Elderly Patients With Previously Untreated Advanced NSCLC Harboring EGFR Mutations
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-88 Osimertinib Maintenance After Definitive Chemoradiation in Patients With Unresectable EGFRm-Positive Stage III NSCLC (LAURA)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-80 ELIOS: A Multicenter, Open-Label, Molecular Profiling Study of Patients With EGFRm and NSCLC Treated With Osimertinib
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
P1.01-100 Concurrent Brain Radiotherapy and EGFR-TKI Have Better Survival Benefits in Patients With Brain Metastases From EGFR-Mutant NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Phase I Clinical Trial Outcomes in 93 Patients With Brain Metastases: The MD Anderson Cancer Center Experience
Clinical Cancer Research
Cancer Research
Oncology
P1.01-60 Preventing and Treating Brain Metastases With Three First-Line EGFR-TKI in Patients With EGFR Mutation Advanced NSCLC
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
MA08.06 Outcomes Among Patients With EGFR-Mutant Metastatic NSCLC With and Without Brain Metastases
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
A Phase II Trial of Sunitinib in Patients With Renal Cell Cancer and Untreated Brain Metastases
Clinical Genitourinary Cancer
Oncology
Urology
MA08.01 Phase 3 Trial of Whole Brain Radiotherapy With Concurrent Erlotinib Versus WBRT Alone for NSCLC With Brain Metastases (ENTER)
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary